BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace


EVQLV logo

United States of America based

EVQLV develops artificial intelligence, engineered with life science data, to accelerate how biologic therapies reach patients. We work with partners at the discovery stage to accelerate the speed of antibody discovery. For those collaborators who have preclinical, clinical, or commercial assets, we support the optimization of antibody candidates, develop assets that expand IP protection, and design next generation and innovative immunotherapies. All of our work is performed at accelerated speeds only feasible by leveraging computational tools that learn from massive and diverse data points.


AI Companies (Drug Discovery)  

R&D Platform

We use data from a range of exponentially growing datasets, which provides us with sequence, structure, biophysical properties, and more. We integrate that data and apply our algorithms and computational models in order to extract knowledge.

EVQLV platform
AI platform

Read more


No pipelines published yet




No services posted yet